Capricor Therapeutics, Inc.
CAPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40,467 | -$22,288 | -$29,020 | -$20,023 |
| Dep. & Amort. | $1,425 | $1,069 | $533 | $246 |
| Deferred Tax | $0 | $0 | $0 | -$310 |
| Stock-Based Comp. | $9,765 | $7,392 | $4,459 | $2,966 |
| Change in WC | -$10,784 | -$11,752 | $28,748 | $182 |
| Other Non-Cash | $66 | -$18 | $196 | $130 |
| Operating Cash Flow | -$39,996 | -$25,597 | $4,917 | -$16,809 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,539 | -$2,048 | -$3,360 | -$1,196 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$208,441 | -$97,442 | -$114,219 | $0 |
| Inv. Sales/Matur. | $93,796 | $104,597 | $82,506 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$116,184 | $5,108 | -$35,073 | -$1,196 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $152,322 | $25,515 | $4,804 | $20,174 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $450 | $65 | $70 | $51 |
| Financing Cash Flow | $152,772 | $25,580 | $4,874 | $20,225 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,408 | $5,092 | -$25,282 | $2,219 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,695 | $9,603 | $34,885 | $32,666 |
| End Cash | $11,287 | $14,695 | $9,603 | $34,885 |
| Free Cash Flow | -$41,535 | -$27,644 | $1,557 | -$18,006 |